EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Ten‐Year Outcomes and Predictors of Mortality Following Catheter Ablation of Ventricular Tachycardia

Laura Rottner iD, Andreas Metzner, Matthias Hochadel iD, Jochen Senges, Stephan Willems, Hüseyin Ince, Lars Eckardt iD, Thomas Deneke iD, Patrick Lugenbiel iD, Johannes Brachmann iD, Julian Chun iD, Roland Tilz iD und 1 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.034814 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Laura Rottner und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology University Heart and Vascular Center Hamburg-Eppendorf Hamburg Germany. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Catheter Ablation, Registries. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Catheter ablation is the primary treatment option for idiopathic ventricular tachycardia (VT). It plays a key role in acute therapy of electrical storm, treatment of VTs in patients with structural heart disease (SHD), and can reduce VT burden. Here we report on 10‐year clinical outcomes following VT ablation from patients enrolled in the prospective German Ablation Registry. Methods and Results Long‐term follow‐up was conducted on 334 patients undergoing VT ablation (118/334, 35%) with structurally normal hearts and 216 out of 334 (65%) with SHD, including 161 out of 216 (75%) with ischemic heart disease at 38 centers. Follow‐up was completed in 94.8% of patients. Median observation time was 10.8 (4.3–12.3) years, with a 10‐year all‐cause mortality rate of 39.4%. VT ablation in patients with SHD was associated with worse outcome when compared with patients with structurally normal hearts (estimated 10‐year mortality for SHD 54.8% versus structurally normal hearts 12.1%). Estimated 10‐year mortality following VT ablation was highest in patients with ischemic heart disease (62.4%). Significant predictors of mortality following VT ablation included age (hazard ratio [HR], 2.35 [1.90–2.92] per decade), left ventricular ejection fraction ≤30% (HR, 2.11 [1.44–3.10]), diabetes (HR, 1.73 [1.14–2.61]), incessant VT (HR, 2.96 [1.74–5.03]), linear lesion (HR, 1.46 [0.99–2.16]), and acute procedural failure (HR, 2.57 [1.39–4.77]). Procedural failure was the only statistically significant predictor for VT recurrence during follow‐up (HR, 3.76 [1.59–8.91]).

Conclusions

Within an all‐comer patient cohort, estimated 10‐year all‐cause mortality following VT ablation is 39.4%. Mortality after VT ablation is worse in patients with SHD and highest for patients with ischemic heart disease. Acute procedural success plays a major role in predicting VT recurrence and long‐term mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularCatheter AblationRegistriesHumansMaleFemaleMiddle AgedAgedTreatment OutcomeGermanyTime FactorsProspective StudiesRisk FactorsFollow-Up StudiesRisk AssessmentRecurrence

Stichwörter der Autor:innen

catheter ablationlong‐term mortalityventricular tachycardia

Autor:innen und Institutionen

  • Department of Cardiology University Heart and Vascular Center Hamburg-Eppendorf Hamburg Germany.
  • Institut für Herzinfarktforschung Ludwigshafen Germany.
  • Department of Cardiology Asklepios Klinik St. Georg Hamburg Germany.
  • Department of Cardiology Vivantes Klinikum am Urban Berlin Germany.
  • Universitätesmedizin Rostock Rostock Germany.
  • Department of Cardiology II University Hospital Muenster Muenster Germany.

ORCID-Profile: Laura Rottner, Matthias Hochadel, Lars Eckardt, Thomas Deneke, Patrick Lugenbiel, Johannes Brachmann, Julian Chun, Roland Tilz, Andreas Rillig

Zitieren

APA

Rottner, L., Metzner, A., Hochadel, M., Senges, J., Willems, S., Ince, H., Eckardt, L., Deneke, T., Lugenbiel, P., Brachmann, J., Chun, J., Tilz, R., & Rillig, A. (2025). Ten‐Year Outcomes and Predictors of Mortality Following Catheter Ablation of Ventricular Tachycardia. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.034814

Vancouver

Rottner L, Metzner A, Hochadel M, Senges J, Willems S, Ince H, et al. Ten‐Year Outcomes and Predictors of Mortality Following Catheter Ablation of Ventricular Tachycardia. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.034814

BibTeX
@article{Rottner2025,
  author = {Rottner, Laura and Metzner, Andreas and Hochadel, Matthias and Senges, Jochen and Willems, Stephan and Ince, Hüseyin and Eckardt, Lars and Deneke, Thomas and Lugenbiel, Patrick and Brachmann, Johannes and Chun, Julian and Tilz, Roland and Rillig, Andreas},
  title = {Ten‐Year Outcomes and Predictors of Mortality Following Catheter Ablation of Ventricular Tachycardia},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.034814}
}
Kostenlos starten →